Cargando…
Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression
TP53 mutations are common in breast cancer and are typically associated with more aggressive tumor characteristics, but little is known about the clinicopathological and epidemiological relevance of p53 protein expression, a TP53 mutation surrogate, in breast cancer subtypes. In this study of 7226 C...
Autores principales: | Abubakar, Mustapha, Guo, Changyuan, Koka, Hela, Sung, Hyuna, Shao, Nan, Guida, Jennifer, Deng, Joseph, Li, Mengjie, Hu, Nan, Zhou, Bin, Lu, Ning, Yang, Xiaohong R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658470/ https://www.ncbi.nlm.nih.gov/pubmed/31372496 http://dx.doi.org/10.1038/s41523-019-0117-7 |
Ejemplares similares
-
Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer
por: Abubakar, Mustapha, et al.
Publicado: (2021) -
Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population
por: Abubakar, Mustapha, et al.
Publicado: (2018) -
Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors
por: Sohn, Yu-Mee, et al.
Publicado: (2016) -
Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
por: Birkman, Eva-Maria, et al.
Publicado: (2017) -
Clinicopathological significance of immunohistochemical expression of Filamin A in breast cancer
por: Joshua, Lokavarapu Manoj, et al.
Publicado: (2020)